Anthony M. Magliocco, MD

BOARD CERTIFICATION:

FELLOWSHIP:
          •  Fox Chase Cancer Center - Molecular Surgical Pathology
          •  College of American Pathologists - Pathology
          •  Royal College of Physicians and Surgeons - Anatomical Pathology

RESIDENCY:
          •  University of Calgary - Anatomical Pathology

MEDICAL SCHOOL:
          •  University of Alberta - MD

• Friedenreich CM, Langley AR, Speidel TP, Lau DC, Courneya KS, Csizmadi I, Magliocco AM, Yasui Y, Cook LS. Case-control study of inflammatory markers and the risk of endometrial cancer. Eur J Cancer Prev. 2013 Jul;22(4):374-379. Pubmedid: 23702681.


• Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ, Strom BL, Spurdle AB, Soslow RA, Shu XO, Schairer C, Sacerdote C, Rohan TE, Robien K, Risch HA, Ricceri F, Rebbeck TR, Rastogi R, Prescott J, Polidoro S, Park Y, Olson SH, Moysich KB, Miller AB, McCullough ML, Matsuno RK, Magliocco AM, Lurie G, Lu L, Lissowska J, Liang X, Lacey JV, Kolonel LN, Henderson BE, Hankinson SE, H?kansson N, Goodman MT, Gaudet MM, Garcia-Closas M, Friedenreich CM, Freudenheim JL, Doherty J, De Vivo I, Courneya KS, Cook LS, Chen C, Cerhan JR, Cai H, Brinton LA, Bernstein L, Anderson KE, Anton-Culver H, Schouten LJ, Horn-Ross PL. Type I and II Endometrial Cancers: Have They Different Risk Factors?. J Clin Oncol. 2013 Jun. Pubmedid: 23733771.


• Lautenschlaeger T, George A, Klimowicz AC, Efstathiou JA, Wu CL, Sandler H, Shipley WU, Tester WJ, Hagan MP, Magliocco AM, Chakravarti A. Bladder Preservation Therapy for Muscle-Invading Bladder Cancers on Radiation Therapy Oncology Group Trials 8802, 8903, 9506, and 9706: Vascular Endothelial Growth Factor B Overexpression Predicts for Increased Distant Metastasis and Shorter Survival. Oncologist. 2013 Jun. Pubmedid: 23728940.


• Amankwah EK, Friedenreich C, Magliocco AM, Brant R, Speidel TP, Rahman W, Cook LS. Hormonal and Reproductive Risk Factors for Sporadic Microsatellite Stable and Unstable Endometrial Tumors. Cancer Epidemiol Biomarkers Prev. 2013 May. Pubmedid: 23677572.


• Cook LS, Nelson HE, Stidley CA, Dong Y, Round PJ, Amankwah EK, Magliocco AM, Friedenreich CM. Endometrial cancer and a family history of cancer. Gynecol Oncol. 2013 May. Pubmedid: 23632205.


• Amankwah EK, Friedenreich CM, Magliocco AM, Brant R, Courneya KS, Speidel T, Rahman W, Langley AR, Cook LS. Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype. Am J Epidemiol. 2013 May;177(12):1378-1387. Pubmedid: 23673247.


• Jagdis A, Phan T, Klimowicz AC, Laskin JJ, Lau HY, Petrillo SK, Siever JE, Thomson TA, Magliocco AM, Hao D. Assessment of ERCC1 and XPF protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients undergoing curative intent treatment. Int J Radiat Oncol Biol Phys. 2013 Apr;85(5):1340-1345. Pubmedid: 23182703.


• Duggan MA, Goswami R, Magliocco AM, Burnier M, Sidhu D. Guidelines for the review of pathology in the research context. Surgery. 2013 Mar. Pubmedid: 23499018.


• McIntyre JB, Wu JS, Craighead PS, Phan T, K?bel M, Lees-Miller SP, Ghatage P, Magliocco AM, Doll CM. PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy. Gynecol Oncol. 2013 Mar;128(3):409-414. Pubmedid: 23266353.


• Doll CM, Aquino-Parsons C, Pintilie M, Klimowicz AC, Petrillo SK, Milosevic M, Craighead PS, Clarke B, Lees-Miller SP, Fyles AW, Magliocco AM. The significance of tumoral ERCC1 status in patients with locally advanced cervical cancer treated with chemoradiation therapy: a multicenter clinicopathologic analysis. Int J Radiat Oncol Biol Phys. 2013 Mar;85(3):721-727. Pubmedid: 22836058.


• Doll CM, Winter K, Gaffney DK, Ryu JK, Jhingran A, Dicker AP, Weidhaas JB, Miller BE, Magliocco AM. COX-2 Expression and Survival in Patients With Locally Advanced Cervical Cancer Treated With Chemoradiotherapy and Celecoxib: A Quantitative Immunohistochemical Analysis of RTOG C0128. Int J Gynecol Cancer. 2013 Jan;23(1):176-183. Pubmedid: 23221733.


• Peck AR, Witkiewicz AK, Liu C, Klimowicz AC, Stringer GA, Pequignot E, Freydin B, Yang N, Ertel A, Tran TH, Girondo MA, Rosenberg AL, Hooke JA, Kovatich AJ, Shriver CD, Rimm DL, Magliocco AM, Hyslop T, Rui H. Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes. Breast Cancer Res. 2012 Oct;14(5):R130. Pubmedid: 23036105.


• Klimowicz AC, Bose P, Nakoneshny SC, Dean M, Huang L, Chandarana S, Magliocco AM, Wayne Matthews T, Brockton NT, Dort JC. Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma. Eur J Cancer. 2012 Sep;48(14):2166-2174. Pubmedid: 22892062.


• Bose P, Klimowicz AC, Kornaga E, Petrillo SK, Waynematthews T, Chandarana S, Magliocco AM, Brockton NT, Dort JC. Bax expression measured by AQUA analysis is an independent prognostic marker in oral squamous cell carcinoma. BMC Cancer. 2012 Aug;12(1):332. Pubmedid: 22852863.


• McIntyre JB, Bose P, Klimowicz AC, Brockton NT, Petrillo S, Matthews W, Easaw J, Magliocco A, Dort JC. Specific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinoma. PLoS One. 2012 Aug;7(2):e31723. Pubmedid: 22359620. Pmcid: PMC3280998.


• Brockton NT, Klimowicz AC, Bose P, Petrillo SK, Konno M, Rudmik L, Dean M, Nakoneshny SC, Matthews TW, Chandarana S, Lau HY, Magliocco AM, Dort JC. High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma. Oral Oncol. 2012 Jul;48(7):615-622. Pubmedid: 22366443.


• Hao D, Lau HY, Eliasziw M, Box A, Diaz R, Klimowicz AC, Shin B, Lees-Miller SP, Magliocco AM. Comparing ERCC1 protein expression, mRNA levels, and genotype in squamous cell carcinomas of the head and neck treated with concurrent chemoradiation stratified by HPV status. Head Neck. 2012 Jun;34(6):785-791. Pubmedid: 22127805.


• Williamson CT, Kubota E, Hamill JD, Klimowicz A, Ye R, Muzik H, Dean M, Tu L, Gilley D, Magliocco AM, McKay BC, Bebb DG, Lees-Miller SP. Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53. EMBO Mol Med. 2012 Jun;4(6):515-527. Pubmedid: 22416035. Pmcid: PMC3443945.


• Kamel-Reid S, Chong G, Ionescu DN, Magliocco AM, Spatz A, Tsao M, Weng X, Young S, Zhang T, Soulieres D. EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer. Curr Oncol. 2012 Apr;19(2):e67-e74. Pubmedid: 22514499. Pmcid: PMC3320234.


• Kangarloo SB, Naveed F, Ng ES, Chaudhry MA, Wu J, Bahlis NJ, Brown CB, Daly A, Duggan P, Geddes M, Quinlan D, Savoie ML, Shafey M, Stewart DA, Storek J, Yang M, Zacarias N, Yue P, Magliocco AM, Russell JA. Development and Validation of a Test Dose Strategy for Once-Daily i.v. Busulfan: Importance of Fixed Infusion Rate Dosing. Biol Blood Marrow Transplant. 2012 Feb;18(2):295-301. Pubmedid: 21801704.


• Friedenreich CM, Langley AR, Speidel TP, Lau DC, Courneya KS, Csizmadi I, Magliocco AM, Yasui Y, Cook LS. Case-control study of markers of insulin resistance and endometrial cancer risk. Endocr Relat Cancer. 2012;19(6):785-792. Pubmedid: 23033315.


• Biel RK, Csizmadi I, Cook LS, Courneya KS, Magliocco AM, Friedenreich CM. Risk of endometrial cancer in relation to individual nutrients from diet and supplements. Public Health Nutr. 2011 Nov;14(11):1948-1960. Pubmedid: 21752313.


• Friedenreich CM, Biel RK, Lau DC, Csizmadi I, Courneya KS, Magliocco AM, Yasui Y, Cook LS. Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2384-2395. Pubmedid: 21921255.


• Bjorge JD, Pang AS, Funnell M, Chen KY, Diaz R, Magliocco AM, Fujita DJ. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line. PLoS One. 2011 Aug;6(4):e19309. Pubmedid: 21541295. Pmcid: PMC3082570.


• Biel RK, Friedenreich CM, Csizmadi I, Robson PJ, McLaren L, Faris P, Courneya KS, Magliocco AM, Cook LS. Case-control study of dietary patterns and endometrial cancer risk. Nutr Cancer. 2011 Jul;63(5):673-686. Pubmedid: 21614724.


• Otsuka S, Klimowicz AC, Kopciuk K, Petrillo SK, Konno M, Hao D, Muzik H, Stolte E, Boland W, Morris D, Magliocco AM, Bebb DG. CXCR4 Overexpression Is Associated with Poor Outcome in Females Diagnosed with Stage IV Non-small Cell Lung Cancer. J Thorac Oncol. 2011 Jul;6(7):1169-1178. Pubmedid: 21623238.


• Woolcott CG, Cook LS, Courneya KS, Boyd NF, Yaffe MJ, Terry T, Brant R, McTiernan A, Bryant HE, Magliocco AM, Friedenreich CM. Associations of overall and abdominal adiposity with area and volumetric mammographic measures among postmenopausal women. Int J Cancer. 2011 Jul;129(2):440-448. Pubmedid: 20848591.


• Peck AR, Witkiewicz AK, Liu C, Stringer GA, Klimowicz AC, Pequignot E, Freydin B, Tran TH, Yang N, Rosenberg AL, Hooke JA, Kovatich AJ, Nevalainen MT, Shriver CD, Hyslop T, Sauter G, Rimm DL, Magliocco AM, Rui H. Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J Clin Oncol. 2011 Jun;29(18):2448-2458. Pubmedid: 21576635.


• Rimm DL, Nielsen TO, Jewell SD, Rohrer DC, Broadwater G, Waldman F, Mitchell KA, Singh B, Tsongalis GJ, Frankel WL, Magliocco AM, Lara JF, Hsi ED, Bleiweiss IJ, Badve SS, Chen B, Ravdin PM, Schilsky RL, Thor A, Berry DA. Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues. J Clin Oncol. 2011 Jun;29(16):2282-2290. Pubmedid: 21519016. Pmcid: PMC3107745.


• Brockton N, Dort J, Lau H, Hao D, Brar S, Klimowicz A, Petrillo S, Diaz R, Doll C, Magliocco A. High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumors. Int J Radiat Oncol Biol Phys. 2011 May;80(1):249-257. Pubmedid: 21300470.


• Hamilton MG, Rold?n G, Magliocco A, McIntyre JB, Parney I, Easaw JC. Determination of the methylation status of MGMT in different regions within glioblastoma multiforme. J Neurooncol. 2011 Apr;102(2):255-260. Pubmedid: 20652362.


• Li Y, Yau A, Schaeffer D, Magliocco A, Gui X, Urbanski S, Waghray R, Owen D, Gao ZH. Colorectal glandular-neuroendocrine mixed tumor: pathologic spectrum and clinical implications. Am J Surg Pathol. 2011 Mar;35(3):413-425. Pubmedid: 21317713.


• Tambasco M, Eliasziw M, Magliocco AM. Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival. J Transl Med. 2011 Mar;8:140. Pubmedid: 21194459. Pmcid: PMC3024250.


• Roa WH, Azarmi S, Al-Hallak MH, Finlay WH, Magliocco AM, L?benberg R. Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model. J Control Release. 2011 Feb;150(1):49-55. Pubmedid: 21059378.


• Lau HY, Brar S, Klimowicz AC, Petrillo SK, Hao D, Brockton NT, Kong CS, Lees-Miller SP, Magliocco AM. Prognostic significance of p16 in locally advanced squamous cell carcinoma of the head and neck treated with concurrent cisplatin and radiotherapy. Head Neck. 2011 Feb;33(2):251-256. Pubmedid: 20848448.


• Koro K, Parkin S, Pohorelic B, Yang AD, Narendran A, Egan C, Magliocco A. Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration. Breast Cancer Res Treat. 2011 Feb;126(1):73-83. Pubmedid: 20401631.


• Blackmore C, Jayanthan A, Ujack E, Magliocco T, Narendran A. Analysis of multiple growth regulatory proteins using dissociable staining antibody arrays on solid tumor biopsy specimens. Fetal Pediatr Pathol. 2011;30(3):177-188. Pubmedid: 21355677.


• Doll CM, Prystajecky M, Eliasziw M, Klimowicz AC, Petrillo SK, Craighead PS, Hao D, Diaz R, Lees-Miller SP, Magliocco AM. Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone. Radiother Oncol. 2010 Nov;97(2):352-359. Pubmedid: 20934765.


• Franko A, Magliocco AM, Duan Q, Duggan MA. WT1 immunoprofiling and comparison of malignant Mullerian mixed tumors of the female genital tract. Int J Gynecol Pathol. 2010 Sep;29(5):452-458. Pubmedid: 20736771.


• Friedenreich CM, Cook LS, Magliocco AM, Duggan MA, Courneya KS. Case-control study of lifetime total physical activity and endometrial cancer risk. Cancer Causes Control. 2010 Jul;21(7):1105-1116. Pubmedid: 20336482. Pmcid: PMC2883088.


• Souli?res D, Greer W, Magliocco AM, Huntsman D, Young S, Tsao MS, Kamel-Reid S. KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies. Curr Oncol. 2010 Jul;17 Suppl 1:S31-S40. Pubmedid: 20680106. Pmcid: PMC2901795.


• Agrawal A, Yau A, Magliocco A, Chu P. Cutaneous metastatic disease in cervical cancer: a case report. J Obstet Gynaecol Can. 2010 May;32(5):467. Pubmedid: 20500956.


• Ahn BY, Elwi AN, Lee B, Trinh DL, Klimowicz AC, Yau A, Chan JA, Magliocco A, Kim SW. Genetic screen identifies insulin-like growth factor binding protein 5 as a modulator of tamoxifen resistance in breast cancer. Cancer Res. 2010 Apr;70(8):3013-3019. Pubmedid: 20354179.


• Torlakovic EE, Riddell R, Banerjee D, El-Zimaity H, Pilavdzic D, Dawe P, Magliocco A, Barnes P, Berendt R, Cook D, Gilks B, Williams G, Perez-Ordonez B, Wehrli B, Swanson PE, Otis CN, Nielsen S, Vyberg M, Butany J. Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests. Am J Clin Pathol. 2010 Mar;133(3):354-365. Pubmedid: 20154273.


• Drabycz S, Rold?n G, de Robles P, Adler D, McIntyre JB, Magliocco AM, Cairncross JG, Mitchell JR. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Neuroimage. 2010 Jan;49(2):1398-1405. Pubmedid: 19796694.


• Alain T, Muzik H, Otsuka S, Chan S, Magliocco T, Diaz R, Forsyth PA, Morris D, Bebb G. Susceptibility of mantle cell lymphomas to reovirus oncolysis. Leuk Res. 2010 Jan;34(1):100-108. Pubmedid: 19651440.


• Terry J, Torlakovic EE, Garratt J, Miller D, K?bel M, Cooper J, Bahzad S, Pilavdzic D, O'Malley F, O'Brien AE, SenGupta S, Alport E, T?tu B, Knight B, Pettigrew NM, Berendt R, Wolber R, Trotter MJ, Riddell RH, Gaboury L, Elms F, Magliocco A, Barnes P, Gown AM, Gilks CB. Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistoc. Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):375-382. Pubmedid: 19363444.


• Rold?n GB, Scott JN, McIntyre JB, Dharmawardene M, de Robles PA, Magliocco AM, Yan ES, Parney IF, Forsyth PA, Cairncross JG, Hamilton MG, Easaw JC. Population-based study of pseudoprogression after chemoradiotherapy in GBM. Can J Neurol Sci. 2009 Sep;36(5):617-622. Pubmedid: 19831132.


• Le QT, Harris J, Magliocco AM, Kong CS, Diaz R, Shin B, Cao H, Trotti A, Erler JT, Chung CH, Dicker A, Pajak TF, Giaccia AJ, Ang KK. Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03. J Clin Oncol. 2009 Sep;27(26):4281-4286. Pubmedid: 19667273. Pmcid: PMC2744270.


• Tambasco M, Costello BM, Kouznetsov A, Yau A, Magliocco AM. Quantifying the architectural complexity of microscopic images of histology specimens. Micron. 2009 Jun;40(4):486-494. Pubmedid: 19171487.


• Agrawal A, Nation J, Ghatage P, Chu P, Ross S, Magliocco A. Malignant chest wall endometriosis: a case report and literature review. J Obstet Gynaecol Can. 2009 Jun;31(6):538-541. Pubmedid: 19646320.


• de Robles P, McIntyre J, Kalra S, Rold?n G, Cairncross G, Forsyth P, Magliocco T, Hamilton M, Easaw J. Methylation status of MGMT gene promoter in meningiomas. Cancer Genet Cytogenet. 2008 Nov;187(1):25-27. Pubmedid: 18992637.


• Sijben AE, McIntyre JB, Rold?n GB, Easaw JC, Yan E, Forsyth PA, Parney IF, Magliocco AM, Bernsen H, Cairncross JG. Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neurooncol. 2008 Aug;89(1):97-103. Pubmedid: 18398569.


• Tambasco M, Magliocco AM. Relationship between tumor grade and computed architectural complexity in breast cancer specimens. Hum Pathol. 2008 May;39(5):740-746. Pubmedid: 18439940.


• Alkushi A, Clarke BA, Akbari M, Makretsov N, Lim P, Miller D, Magliocco A, Coldman A, van de Rijn M, Huntsman D, Parker R, Gilks CB. Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data. Mod Pathol. 2007 Nov;20(11):1156-1165. Pubmedid: 17717550.


• Lazebnik M, Popovic D, McCartney L, Watkins CB, Lindstrom MJ, Harter J, Sewall S, Ogilvie T, Magliocco A, Breslin TM, Temple W, Mew D, Booske JH, Okoniewski M, Hagness SC. A large-scale study of the ultrawideband microwave dielectric properties of normal, benign and malignant breast tissues obtained from cancer surgeries. Phys Med Biol. 2007 Oct;52(20):6093-6115. Pubmedid: 17921574.


• Hanna W, O'malley FP, Barnes P, Berendt R, Gaboury L, Magliocco A, Pettigrew N, Robertson S, Sengupta S, T?tu B, Thomson T. Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer. Curr Oncol. 2007 Aug;14(4):149-153. Pubmedid: 17710207. Pmcid: PMC1948868.


• Duggan MA, Akbari M, Magliocco AM. Atypical immature cervical metaplasia: immunoprofiling and longitudinal outcome. Hum Pathol. 2006 Nov;37(11):1473-1481. Pubmedid: 16949917.


• Cook LS, Kmet LM, Magliocco AM, Weiss NS. Endometrial cancer survival among U.S. black and white women by birth cohort. Epidemiology. 2006 Jul;17(4):469-472. Pubmedid: 16755263.


• Brown LA, Irving J, Parker R, Kim H, Press JZ, Longacre TA, Chia S, Magliocco A, Makretsov N, Gilks B, Pollack J, Huntsman D. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. Gynecol Oncol. 2006 Feb;100(2):264-270. Pubmedid: 16236351.


• Rudmik LR, Magliocco AM. Molecular mechanisms of hepatic metastasis in colorectal cancer. J Surg Oncol. 2005 Dec;92(4):347-359. Pubmedid: 16299807.


• Murthy SK, Magliocco AM, Demetrick DJ. Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization. Arch Pathol Lab Med. 2005 Jan;129(1):39-46. Pubmedid: 15628907.


• Woo MM, Alkushi A, Verhage HG, Magliocco AM, Leung PC, Gilks CB, Auersperg N. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer. Clin Cancer Res. 2004 Dec;10(23):7958-7964. Pubmedid: 15585630.


• Chagpar A, Magliocco A, Kerviche A, Tan L, Walley B, DeCoteau JF. The replication error phenotype is associated with the development of distant metastases in hormonally treated patients with breast carcinoma. Cancer. 2004 Mar;100(5):913-919. Pubmedid: 14983485.


• Cook LS, White JL, Stuart GC, Magliocco AM. The reliability of telephone interviews compared with in-person interviews using memory aids. Ann Epidemiol. 2003 Aug;13(7):495-501. Pubmedid: 12932624.


• Wang XD, Rosales JL, Magliocco A, Gnanakumar R, Lee KY. Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene. 2003 Feb;22(5):769-774. Pubmedid: 12569370.


• Scott S, Kimura T, Ichinohasama R, Bergen S, Magliocco A, Reimer C, Kerviche A, Sheridan D, DeCoteau JF. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation. Leuk Res. 2003 Jan;27(1):23-34. Pubmedid: 12479849.


• Kmet LM, Cook LS, Magliocco AM. A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors. Cancer. 2003 Jan;97(2):389-404. Pubmedid: 12518363.


• Arcellana-Panlilio MY, Egeler RM, Ujack E, Magliocco A, Stuart GC, Robbins SM, Coppes MJ. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors. Genes Chromosomes Cancer. 2002 Oct;35(2):176-181. Pubmedid: 12203782.


• Choi KS, Fitzpatrick SL, Filipenko NR, Fogg DK, Kassam G, Magliocco AM, Waisman DM. Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer. J Biol Chem. 2001 Jul;276(27):25212-25221. Pubmedid: 11319229.


• Magliocco A, Brilliant M. One-dimensional genome scanning-detection of genomic changes in ovarian carcinoma. Methods Mol Med. 2001;39:357-364. Pubmedid: 21340791.


• Campbell I, Magliocco A, Moyana T, Zheng C, Xiang J. Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growth. Cancer Gene Ther. 2000 Sep;7(9):1270-1278. Pubmedid: 11023200.


• Al-Hendy A, Magliocco AM, Al-Tweigeri T, Braileanu G, Crellin N, Li H, Strong T, Curiel D, Chedrese PJ. Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model. Am J Obstet Gynecol. 2000 Mar;182(3):553-559. Pubmedid: 10739507.


• Lowsky R, Magliocco A, Ichinohasama R, Reitmair A, Scott S, Henry M, Kadin ME, DeCoteau JF. MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. Blood. 2000 Mar;95(5):1767-1772. Pubmedid: 10688836.


• Kanthan R, Xiang J, Magliocco AM. p53, ErbB2, and TAG-72 expression in the spectrum of ductal carcinoma in situ of the breast classified by the Van Nuys system. Arch Pathol Lab Med. 2000 Feb;124(2):234-239. Pubmedid: 10656732.


• Toyama T, Iwase H, Watson P, Muzik H, Saettler E, Magliocco A, DiFrancesco L, Forsyth P, Garkavtsev I, Kobayashi S, Riabowol K. Suppression of ING1 expression in sporadic breast cancer. Oncogene. 1999 Sep;18(37):5187-5193. Pubmedid: 10498868.


• Al-Tweigeri T, Magliocco AM, DeCoteau JF. Cortical blindness as a manifestation of hypomagnesemia secondary to cisplatin therapy: case report and review of literature. Gynecol Oncol. 1999 Jan;72(1):120-122. Pubmedid: 9889044.


• Thompson TS, Treble RG, Magliocco A, Roettger JR, Eichhorst JC. Case study: fatal poisoning by malathion. Forensic Sci Int. 1998 Jul;95(2):89-98. Pubmedid: 9722973.


• Brilliant MH, Gondo Y, Magliocco A. One-dimensional genome scanning: identification of the basis of a mouse mutation and identification of genomic changes in ovarian carcinoma. Electrophoresis. 1995 Feb;16(2):163-167. Pubmedid: 7774555.


• Magliocco AM, Brilliant MH. Genome scanning detects genetic alterations in human ovarian carcinoma. Hum Mutat. 1994;4(2):141-149. Pubmedid: 7981718.


• Demetrick DJ, Magliocco AM, Hwang WS. Absence of varicella zoster DNA in varicella embryopathy tissue utilizing the polymerase chain reaction. Pediatr Pathol. 1993 May;13(3):345-355. Pubmedid: 8390647.


• Magliocco AM, Demetrick DJ, Sarnat HB, Hwang WS. Varicella embryopathy. Arch Pathol Lab Med. 1992 Feb;116(2):181-186. Pubmedid: 1733414.


• Magliocco AM, Demetrick DJ, Jones AR, Kossakowska AE. Granulocytic sarcoma of the ovary. An unusual case presentation. Arch Pathol Lab Med. 1991 Aug;115(8):830-834. Pubmedid: 1863196.


• Magliocco A, Miller K, Robertson DI, Gill MJ. Occurrence of Pneumocystis carinii organisms in a peritoneal effusion from a patient with the acquired immunodeficiency syndrome. Diagn Cytopathol. 1991;7(5):540-542. Pubmedid: 1954838.


• Magliocco AM, Mitchell LB, Brownell AK, Lester WM. Dilated cardiomyopathy in multicore myopathy. Am J Cardiol. 1989 Jan;63(1):150-151. Pubmedid: 2909155.

My clinical interests focus on molecular biomarker development for improving cancer treatment. In addition I have special expertise in breast and gynecological pathology.  Finally, I have interests in developing approaches for improving the quality of cancer pathology laboratories.